The development of new accelerators has given a new impetus to the development of new
drugs and treatment technologies using boron neutron capture therapy (BNCT). We …

Boron neutron capture therapy (BNCT) is a binary radiotherapeutic modality based on the
nuclear capture and fission reactions that occur when the stable isotope, boron-10, is …

Boron neutron capture therapy (BNCT) has a unique property of tumor-cell-selective heavy-
particle irradiation. BNCT can form large dose gradients between cancer cells and normal …

Boron neutron capture therapy (BNCT) is a binary therapeutic modality based on the nuclear
capture and fission reactions that occur when the stable isotope boron-10 is irradiated with …

Our growing understanding of membrane transporters and their substrate specificity has
opened a new avenue in the field of targeted drug delivery. The L-type amino acid …

Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on
the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is …

In this paper, we discuss the role of particle therapy—a novel radiation therapy (RT) that has
shown rapid progress and widespread use in recent years—in multidisciplinary treatment …

Boron neutron capture therapy (BNCT) was first proposed as early as 1936, and research on
BNCT has progressed relatively slowly but steadily. BNCT is a potentially useful tool for …

Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on
the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is …

Glioblastoma is the most common brain primary malignant tumor with the highest mortality.
Boron neutron capture therapy (BNCT) can efficiently kill cancer cells on the cellular scale …